FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 332:1712-1714 June 22, 1995 Number 25 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

The treatment of acute myeloblastic leukemia (AML) is often portrayed as one of the successes of modern hematology. In 1966, the year before I qualified as a doctor, the median survival of adults with acute leukemia was 40 days.¹ Only 10 percent had remission of their disease. Nowadays, it is commonplace to hear of remission rates of 80 percent and to talk about cure. Such optimism is misleading. There is a subgroup of young adults, particularly those with favorable chromosomal translocations, in whom the outlook is much less bleak than it was. But most cases of AML occur in patients . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Chen, C.-C., Yang, C.-F., Yang, M.-H., Lee, K.-D., Kwang, W.-K., You, J.-Y., Yu, Y.-B., Ho, C.-H., Tzeng, C.-H., Chau, W.-K., Hsu, H.-C., Gau, J.-P. (2005). Pretreatment prognostic factors and treatment outcome in elderly patients with de novo acute myeloid leukemia. Ann Oncol 16: 1366-1373 [Abstract] [Full Text]  
• Song, M.-G., Gao, S.-M., Du, K.-M., Xu, M., Yu, Y., Zhou, Y.-H., Wang, Q., Chen, Z., Zhu, Y.-S., Chen, G.-Q. (2005). Nanomolar concentration of NSC606985, a camptothecin analog, induces leukemic-cell apoptosis through protein kinase C{delta}-dependent mechanisms. Blood 105: 3714-3721 [Abstract] [Full Text]  
• Witz, F., Sadoun, A., Perrin, M.-C., Berthou, C., Briere, J., Cahn, J.-Y., Lioure, B., Witz, B., Francois, S., Desablens, B., Pignon, B., Le Prise, P.-Y., Audhuy, B., Caillot, D., Casassus, P., Delain, M., Christian, B., Tellier, Z., Polin, V., Hurteloup, P., Harousseau, J.-L. (1998). A Placebo-Controlled Study of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor Administered During and After Induction Treatment for De Novo Acute Myelogenous Leukemia in Elderly Patients. Blood 91: 2722-2730 [Abstract] [Full Text]  
• Baer, M. R., Stewart, C. C., Lawrence, D., Arthur, D. C., Byrd, J. C., Davey, F. R., Schiffer, C. A., Bloomfield, C. D. (1997). Expression of the Neural Cell Adhesion Molecule CD56 Is Associated With Short Remission Duration and Survival in Acute Myeloid Leukemia With t(8; 21)(q22; q22). Blood 90: 1643-1648 [Abstract] [Full Text]